T. Rowe Price Associates
LIAN

T. Rowe Price Associates’s LianBio American Depositary Shares LIAN Stock Holding History

T. Rowe Price Associates’s Portfolio LIAN Stock Details LIAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,598,766
Closed -$3.87M – 2935
2023
Q3 		$3.87M Sell
2,598,766
-111,448
-4% -$212K ﹤0.01% 1240
2023
Q2 		$6.18M Buy
2,710,214
+172,605
+7% +$397K ﹤0.01% 1155
2023
Q1 		$4.95M Sell
2,537,609
-143,888
-5% -$298K ﹤0.01% 1186
2022
Q4 		$4.4M Sell
2,681,497
-141,360
-5% -$220K ﹤0.01% 1218
2022
Q3 		$5.62M Buy
2,822,857
+695,979
+33% +$1.66M ﹤0.01% 1177
2022
Q2 		$4.59M Sell
2,126,878
-115,511
-5% -$392K ﹤0.01% 1433
2022
Q1 		$8.09M Hold
2,242,389
– – ﹤0.01% 1397
2021
Q4 		$13.4M Buy
+2,242,389
New +$25.6M ﹤0.01% 1358

Other funds holding LIAN

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

T. Rowe Price Associates's LIAN Position: Q4 2023 in Review

T. Rowe Price Associates sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 2,598,766 shares — an estimated $3.87M sold.

T. Rowe Price Associates first reported a position in LIAN in Q4 2021 and held it in 8 quarters. The position peaked at $13.4M in Q4 2021. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

  • T. Rowe Price Associates reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 2,598,766 LianBio American Depositary Shares shares in Q4 2023, an estimated $3.87M.
  • T. Rowe Price Associates first reported a position in LianBio American Depositary Shares in Q4 2021 and held it in 8 quarters.
  • T. Rowe Price Associates's LianBio American Depositary Shares position peaked at $13.4M in Q4 2021.
  • 29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.